Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T.
about
Hepatic fat fraction and visceral adipose tissue fatty acid composition in mice: Quantification with 7.0T MRI.Quantification of the triglyceride fatty acid composition with 3.0 T MRI.Pancreatic iron and fat assessment by MRI-R2* in patients with iron overload diseases.Influence of fat on liver T1 measurements using modified Look-Locker inversion recovery (MOLLI) methods at 3TMR quantification of total liver fat in patients with impaired glucose tolerance and healthy subjectsStereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRICombined quantification of fatty infiltration, T 1-relaxation times and T 2*-relaxation times in normal-appearing skeletal muscle of controls and dystrophic patients.Multiple breath-hold proton spectroscopy of human liver at 3T: Relaxation times and concentrations of glycogen, choline, and lipids.Noninvasive fat quantification of the liver and pancreas may provide potential biomarkers of impaired glucose tolerance and type 2 diabetesQuantification of pancreatic fat with dual-echo imaging at 3.0-T MR in clinical application: how do the corrections for T1 and T2* relaxation effect work and simplified correction strategy.Simultaneous MR quantification of hepatic fat content, fatty acid composition, transverse relaxation time and magnetic susceptibility for the diagnosis of non-alcoholic steatohepatitis.Comparison of T1 relaxation times in adipose tissue of severely obese patients and healthy lean subjects measured by 1.5 T MRI.Non-Invasive Electrical Impedance Tomography for Multi-Scale Detection of Liver Fat Content.
P2860
Q30488507-078AB4DD-2244-4346-933E-F1A125CE1C79Q30842915-260E61D2-A3C9-46E5-8791-11464FFD12B2Q30853786-183646CA-C0C7-4E1E-87C5-BBA7FEBDD248Q31036723-DF4DD5AF-DC04-426D-B423-B735F405A56EQ34400980-BA9F3A97-D37E-4E79-8B0A-EF1C2692FA94Q36097591-4871915B-7191-4EF6-BB90-5B5B80911657Q36319212-99C70FF0-7E97-4469-9CE5-853F2CB6F6F0Q36350022-3429C693-7FF0-45AA-B344-731649367C04Q37003707-0FD35B40-CB67-4CAF-87F8-B2F58ECB449DQ47747512-49DC7EA4-8809-4F30-B010-F740A9FA31E9Q47982963-9C2B692C-6889-451B-A25B-93A5372630B1Q51063982-D5D8266A-1B45-4944-A286-2733AC721C09Q52647659-1D010858-FD0F-48EA-8212-082481CA96E6
P2860
Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Liver fat volume fraction quan ...... iver disease at 1.5 and 3.0 T.
@ast
Liver fat volume fraction quan ...... iver disease at 1.5 and 3.0 T.
@en
type
label
Liver fat volume fraction quan ...... iver disease at 1.5 and 3.0 T.
@ast
Liver fat volume fraction quan ...... iver disease at 1.5 and 3.0 T.
@en
prefLabel
Liver fat volume fraction quan ...... iver disease at 1.5 and 3.0 T.
@ast
Liver fat volume fraction quan ...... iver disease at 1.5 and 3.0 T.
@en
P2093
P2860
P1433
P1476
Liver fat volume fraction quan ...... liver disease at 1.5 and 3.0 T
@en
P2093
Frank Pilleul
Hélène Ratiney
Olivier Beuf
P2860
P2888
P304
P356
10.1007/S00330-013-2826-X
P407
P577
2013-04-16T00:00:00Z